CollabRx (CLRX) climbs higher before the bell after announcing genetic diagnostics firm...


CollabRx (CLRX) climbs higher before the bell after announcing genetic diagnostics firm Sengenics will incorporate CLRX's interpretive analytics into its cancer diagnostic tests. Shares +10.75% premarket. 

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs